Skip to main content
< Back
About
About the conference
Organisers & Partners
Registration
App
Podcast
Early Career Researchers
Call for abstracts
Guidelines
Latest updates
Press room
Venue
Programme
Full programme
Programme outline
Tracks
Speakers
All speakers
Keynote speakers
Side events
Subscribe
Programme
Keywords
Africa
Alcohol
Asia
Basic research
Behavioural addictions
Cannabis
Capacity-building
Civil society
Clinical research/practice
Comorbidity
COVID-19
Criminal justice/prisons
Criminology
Drug user's perspectives
E-health/digitalisation
ECR (Early Career Researchers)
Europe
Gender perspectives
Harm reduction
Health inequalities
Hepatitis
HIV
Infectious diseases
Markets
Mental health and wellbeing
Monitoring and evaluation
Neuroscience
New psychoactive substances
Nicotine/tobacco
North America
Oceania
Opiates
Overdose
Policy
Prescription drugs
Prevention
Psychostimulants
Public health
Qualitative methods
Quantitative methods
Recreational setting
Risky behaviours
South America
Toxicology and forensic analysis
Treatment
Underrepresented groups
Workforce
Youth/children
- Any -
WED
23 OCT
THU
24 OCT
FRI
25 OCT
All
Plenary session
Big debate
Major session
Workshop
Oral presentation session
Short communication session
e-short communication session
e-poster session
Video contest
PDF version
Wed 23 Oct
10:00
e-poster session day 1
10:00
to
19:20
Digital kiosks
e-poster session
e-poster session day 1
10:00
to
19:20
Digital kiosks
e-poster session
e-poster session day 1
10:00
to
19:20
Digital kiosks
e-poster session
11:50
Cannabis legalisation in Canada and the US: policy variation, state of the evidence and ideas for future research
11:50
to
13:20
Auditorium I
Major session
Advancing addiction research: global perspectives and collaborative initiatives
11:50
to
13:20
Auditorium VI
Oral presentation session
Mechanisms and outcomes in substance use prevention among youth
11:50
to
13:20
Room 5A
Oral presentation session
Mechanisms and outcomes in substance use prevention among youth
11:50
to
13:20
Room 5A
Oral presentation session
Building addiction workforce capacity
11:50
to
13:20
Room 5C
Oral presentation session
Treatment of alcohol use disorder
11:50
to
13:20
Room 1.05
Short communication session
Support for recovery
11:50
to
13:20
Room 1.07
Short communication session
Evaluation of drug consumption rooms: guidance step by step
11:50
to
13:20
Room 1.15
Workshop
14:20
Neuroscience and cognition
14:20
to
15:50
Auditorium III
Short communication session
Legal shifts and their Impact on drug use and sentencing
14:20
to
15:50
Auditorium IV
Oral presentation session
Legal shifts and their Impact on drug use and sentencing
14:20
to
15:50
Auditorium IV
Oral presentation session
Gender and substance use
14:20
to
15:50
Auditorium VIII
Oral presentation session
Gender and substance use
14:20
to
15:50
Auditorium VIII
Oral presentation session
Learning from Africa: workforce development, enhancement and support
14:20
to
15:50
Room 5C
Oral presentation session
Challenge of measuring use and impact of cannabinoids
14:20
to
15:50
Room 1.07
Oral presentation session
Challenge of measuring use and impact of cannabinoids
14:20
to
15:50
Room 1.07
Oral presentation session
Methods and measurement
14:20
to
15:50
Room 1.08
Short communication session
Methods and measurement
14:20
to
15:50
Room 1.08
Short communication session
The peer model: the critical role of ethics in efficacy
14:20
to
15:50
Room 1.15
Workshop
16:00
The recovery journey
16:00
to
17:30
Auditorium III
Oral presentation session
Measuring drug market phenomenon
16:00
to
17:30
Auditorium VI
Oral presentation session
Substance use and psychosis
16:00
to
17:30
Auditorium VII
Oral presentation session
Conceptualising health and harms
16:00
to
17:30
Room 1.08
Short communication session
LEGO® SERIOUS PLAY® Hands-On Workshop on Optimizing Workplace and Well-Being for Workers in Addiction Fields
16:00
to
17:30
Room 1.15
Workshop
17:50
NPS: trends, concerns and response strategies
17:50
to
19:20
Auditorium III
Oral presentation session
Drug use trends
17:50
to
19:20
Auditorium IV
Oral presentation session
Decriminalisation and alternatives to arrest
17:50
to
19:20
Auditorium VI
Oral presentation session
Understanding interrelationships: mental health and substance use
17:50
to
19:20
Auditorium VII
Oral presentation session
Hepatitis C, HIV, and other drug related harms
17:50
to
19:20
Room 1.05
Short communication session
Capacity-building through competencies for the substance use workforce
17:50
to
19:20
Room 1.10
Workshop
Thu 24 Oct
10:00
Workshop on conducting drug research in prison: Challenges and key recommendations from the European experience
10:00
to
11:30
Room 1.15
Workshop
11:50
Innovative methods for understanding drug markets and policy
11:50
to
13:20
Room 5A
Oral presentation session
Innovative methods for understanding drug markets and policy
11:50
to
13:20
Room 5A
Oral presentation session
Workers reaching marginalised groups
11:50
to
13:20
Room 5C
Oral presentation session
Natural language processing for addiction research: a practical primer
11:50
to
13:20
Room 1.06
Workshop
Contemporary issues
11:50
to
13:20
Room 1.08
Oral presentation session
Back-casting exercise on peer-support workforce development
11:50
to
13:20
Room 1.15
Workshop
14:20
Novel neurobiology - cannabis, cognition and craving
14:20
to
15:50
Auditorium III
Oral presentation session
Conceptual frameworks for studying drug policy
14:20
to
15:50
Auditorium VI
Oral presentation session
Young people, mental health and substance use
14:20
to
15:50
Auditorium VII
Oral presentation session
Public health and safety impacts of cannabis legalization in Canada: five years in review
14:20
to
15:50
Auditorium IV
Oral presentation session
Pregnancy, drug use and care
14:20
to
15:50
Room 5B
Oral presentation session
Co-creating robust systems with workers
14:20
to
15:50
Room 5C
Oral presentation session
European prevention curriculum: increasing the use of evidence-based prevention
14:20
to
15:50
Room 1.06
Short communication session
Scenarios for the future of addictions fields by 2040
14:20
to
15:50
Room 1.10
Workshop
16:00
NPS: Pharmacological Characterization and Substance Analysis
16:00
to
17:30
Auditorium III
Oral presentation session
NPS: Pharmacological Characterization and Substance Analysis
16:00
to
17:30
Auditorium III
Oral presentation session
Cannabis legalisation — models and impacts
16:00
to
17:30
Auditorium VI
Oral presentation session
Protective and risk factors in drug prevention
16:00
to
17:30
Room 5A
Oral presentation session
Policy issues in gambling
16:00
to
17:30
Room 5B
Oral presentation session
From genes to brains
16:00
to
17:30
Room 1.06
Short communication session
From genes to brains
16:00
to
17:30
Room 1.06
Short communication session
Drug trends: experiences from Brazil, the Netherlands, Portugal, and Spain
16:00
to
17:30
Room 1.08
Oral presentation session
Drug trends: experiences from Brazil, the Netherlands, Portugal, and Spain
16:00
to
17:30
Room 1.08
Oral presentation session
How to respond to real-time drug alerts in European countries ?
16:00
to
17:30
Room 1.15
Workshop
17:50
Mixed methods for understanding drug use
17:50
to
19:20
Auditorium III
Oral presentation session
Misuse of medicines
17:50
to
19:20
Auditorium VIII
Oral presentation session
New Research on Alcohol and Tobacco Policy
17:50
to
19:20
Room 5A
Oral presentation session
Hospital-based treatments
17:50
to
19:20
Room 5B
Oral presentation session
Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform
17:50
to
19:20
Room 1.06
Short communication session
Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform
17:50
to
19:20
Room 1.06
Short communication session
Internet, smartphones and social media use
17:50
to
19:20
Room 1.07
Short communication session
ScaleUp: Options for scalable psychosocial and pharmacological treatment of stimulant use disorder
17:50
to
19:20
Room 1.08
Oral presentation session
A two-phased augmentation/intervention extension of Claremont’s media-based prevention education model
17:50
to
19:20
Room 1.10
Workshop
Toolkit to Deal with Female Drug User Victims of Gender-Based Violence
17:50
to
19:20
Room 1.15
Workshop
Fri 25 Oct
10:00
A comparative discussion on the role, challenges, and opportunities for addiction nurses within Europe
10:00
to
11:30
Room 1.15
Workshop
11:50
Psychedelics 2
11:50
to
13:20
Auditorium VI
Oral presentation session
Drugs checking services
11:50
to
13:20
Room 5A
Oral presentation session
Online monitoring
11:50
to
13:20
Room 5B
Oral presentation session
Emerging challenges in drug markets: monitoring, measurement & impacts
11:50
to
13:20
Room 1.05
Short communication session
How can cannabis policy goals inform the development of evaluation indicators?
11:50
to
13:20
Room 1.08
Workshop
14:20
Young people and drugs
14:20
to
15:50
Auditorium III
Oral presentation session
Substance use and mental health in prison settings
14:20
to
15:50
Auditorium VII
Oral presentation session
Regulating cannabis supply policies in Europe: navigating the long road to change
14:20
to
15:50
Auditorium VIII
Oral presentation session
Impact of drug policy on drug production & markets
14:20
to
15:50
Room 5B
Oral presentation session
16:00
Novel psychoactive substances and latest drug trends in Asia and Pacific countries
16:00
to
17:30
Room 1.05
Oral presentation session
MENU
Back
www.lisbonaddictions.eu
My profile
Notifications
My favourites
Scan contacts
My contacts
Settings